Research Topics
Species | Edwin A M GaleSummaryAffiliation: University of Bristol Country: UK Publications
| Collaborators
|
Detail Information
Publications
Viruses and type 1 diabetes: ignorance acquires a better vocabularyE A M Gale
University of Bristol, Bristol, UK
Clin Exp Immunol 168:1-4. 2012..Secondary or tertiary roles remain possible, but have yet to be confirmed in prospective studies...
The Hawthorne studies-a fable for our times?E A M Gale
Medical School Unit, Southmead Hospital, Bristol, UK
QJM 97:439-49. 2004
Is there really an epidemic of type 2 diabetes?Edwin A M Gale
Diabetes and Metabolism, Medical School Unit, Southmead Hospital, Bristol BS10 5NB, UK
Lancet 362:503-4. 2003
Spring harvest? Reflections on the rise of type 1 diabetesE A M Gale
Diabetes and Metabolism, Medical School Unit, Southmead Hospital, Bristol, BS10 5NB, UK
Diabetologia 48:2445-50. 2005
Dying of diabetesEdwin A M Gale
Diabetes and Metabolism, Department of Clinical Science, University of Bristol, Southmead Hospital, Bristol BS10 5NB, UK
Lancet 368:1626-8. 2006
A missing link in the hygiene hypothesis?E A M Gale
Diabetes and Metabolism, Division of Medicine, University of Bristol, UK
Diabetologia 45:588-94. 2002..This hypothesis could be tested in case-control studies by the development of serological markers or skin testing. If confirmed, identification of the underlying mechanisms could open the way to new forms of immune intervention...
Recruitment to a clinical trial improves glycemic control in patients with diabetesEdwin A M Gale
Department of Diabetes and Metabolism, University of Bristol, Bristol, UK
Diabetes Care 30:2989-92. 2007..We assessed the effect upon A1C of recruitment to a clinical trial in patients with diabetes who had been screened and interviewed to determine eligibility but whose therapy was otherwise unchanged...
Lessons from the glitazones: a story of drug developmentE A Gale
Diabetes Metabolism, Medical School Unit, Southmead Hospital, 10HA 5NB, Bristol, UK
Lancet 357:1870-5. 2001..How should we use the glitazones? And how did they achieve blockbuster status without any clear evidence of advantage over existing therapy?..
The discovery of type 1 diabetesE A Gale
Diabetes and Metabolism, Division of Medicine, University of Bristol, UK
Diabetes 50:217-26. 2001..Appreciation of the historical origin and subsequent evolution of these fundamental concepts could stimulate critical analysis and help prepare the way for a new paradigm...
Should we dump the metabolic syndrome? YesEdwin A M Gale
Diabetes and Metabolism, University of Bristol, Medical School Unit, Southmead Hospital, Bristol BS10 5NB
BMJ 336:640. 2008
Glucose control in the UKPDS: what did we learn?E A M Gale
Diabetes and Metabolism, Division of Medicine, University of Bristol, Bristol, UK
Diabet Med 25:9-12. 2008..It also taught us that glucose control is not enough: the central objective of therapy is to reduce vascular risk by any means available. This commentary looks back along the winding road that led to these conclusions...
A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial GroupE A Gale
Diabetes and Metabolism, Medical School Unit, Southmead Hospital, University of Bristol, UK
Diabet Med 17:209-14. 2000..This study compared insulin lispro with human soluble insulin in patients with Type 1 diabetes mellitus on multiple injection therapy who inject shortly before meals...
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M Gale
Division of Medicine, University of Bristol
Clin Med 3:538-41. 2003..In the absence of effective sanctions, each of us must seek a personal solution to the professional and ethical issues involved...
The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypesKathleen M Gillespie
Diabetes and Metabolism, Division of Medicine, University of Bristol, Bristol, UK
Lancet 364:1699-700. 2004..003), especially in those diagnosed at age 5 years or younger, which is consistent with the hypothesis that the rise of type 1 diabetes is due to a major environmental effect...
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)Polly J Bingley
Clinical Science at North Bristol, University of Bristol, UK
Diabetes Care 31:146-50. 2008..We wanted to see whether measures of insulin resistance improved risk assessment in islet cell antibody (ICA)-positive relatives when added to other immune and metabolic markers...
Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United KingdomA Paul Lambert
Division of Medicine, University of Bristol, Bristol BS10 5NB, United Kingdom
J Clin Endocrinol Metab 89:4037-43. 2004..4%), whereas inclusion of 11 genotypes achieved the same sensitivity for diagnosis for ages 10-14 yr. Analysis of genotype-specific risk should form the basis for design of future primary prevention trials in the general population...
Islet autoimmunity in children with Down's syndromeKathleen M Gillespie
Medical School Unit, Southmead Hospital, Bristol BS10 5NB, UK
Diabetes 55:3185-8. 2006..Other factors, possibly including genes on chromosome 21, may increase the penetrance of type 1 diabetes in Down's syndrome...
Is puberty an accelerator of type 1 diabetes in IL6-174CC females?Kathleen M Gillespie
Department of Diabetes and Metabolism, Division of Medicine, University of Bristol, UK
Diabetes 54:1245-8. 2005..012). These data support the hypothesis that pubertal changes may contribute to accelerated onset of type 1 diabetes in genetically susceptible females. This phenomenon may be orchestrated by the action of estrogen on the IL6 promoter...
The rise of childhood type 1 diabetes in the 20th centuryEdwin A M Gale
Department of Diabetes and Metabolism, Division of Medicine, University of Bristol, Medical School Unit, Southmead Hospital, Bristol BS10 5NB, U.K
Diabetes 51:3353-61. 2002..The disease process underlying type 1 diabetes has changed over time and continues to evolve. Understanding why and how this produced the pandemic of childhood diabetes would be an important step toward reversing it...
HLA class II typing of whole genome amplified mouth swab DNAK M Gillespie
Diabetes and Metabolism, Division of Medicine, University of Bristol, UK
Tissue Antigens 56:530-8. 2000..We have optimised conditions for HLA class II typing on whole genome amplified DNA collected by mouth swab, but this method could potentially be applied to low concentrations of DNA from other sources...
Optimized autoantibody-based risk assessment in family members. Implications for future intervention trialsP J Bingley
Division of Medicine, University of Bristol, U K
Diabetes Care 22:1796-801. 1999..To determine the best autoantibody-based testing strategy for recruiting relatives for future intervention trials and to establish the role of islet cell antibodies (ICAs) within this strategy...
High familial risk and genetic susceptibility in early onset childhood diabetesKathleen M Gillespie
Department of Diabetes and Metabolism, Division of Medicine, University of Bristol, Bristol, UK
Diabetes 51:210-4. 2002..001). Diabetes with onset before age 5 years is therefore a marker of high familial risk...
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunityA J Williams
Diabetes and Metabolism Division of Medicine, University of Bristol, UK
Diabetes Care 24:504-9. 2001..The high prevalence of celiac autoimmunity may be explained by shared genetic susceptibility and identifies a population within which screening for the disease may be justified...
Survival of the fittest? Natural selection in islet transplantationRichard M Smith
Division of Medicine, University of Bristol, United Kingdom
Transplantation 79:1301-3. 2005..Input from "transplanters" and diabetologists is essential in order to select appropriate patients for islet transplantation...
Diabetes and genderE A Gale
Diabetes and Metabolism, Division of Medicine, University of Bristol, UK
Diabetologia 44:3-15. 2001..Women are, however, more likely to transmit Type II diabetes to their offspring. Understanding these experiments of nature might suggest ways of influencing the early course of both forms of the disease...
The market in diabetesAlexandra Hauber
Diabetologia 49:247-52. 2006
Troglitazone: the lesson that nobody learned?Edwin A M Gale
Diabetologia 49:1-6. 2006
Can we change the course of beta-cell destruction in type 1 diabetes?Edwin A M Gale
N Engl J Med 346:1740-2. 2002
Why can't we prevent type 1 diabetes?: maybe it's time to try a different combinationDesmond Schatz
Department of Pediatrics, University of Florida, Gainesville, Florida, USA
Diabetes Care 26:3326-8. 2003
Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetesSusan P Laing
Institute of Cancer Research, London, UK
Stroke 34:418-21. 2003..Cerebrovascular mortality rates have been shown to be raised in patients with type II diabetes but have not previously been reported by age and sex in patients with type I diabetes...
Your journal and mineEdwin A M Gale
Diabetologia 48:1-2. 2005
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerismJ Lee Nelson
Human Immunogenetics, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109, USA
Proc Natl Acad Sci U S A 104:1637-42. 2007..Thus, T1D patients have higher levels of MMc in their circulation than unaffected siblings and healthy individuals, and MMc contributes to islet beta cells in a mother's progeny...
Infant diets and type 1 diabetes: too early, too late, or just too complicated?Mark Atkinson
JAMA 290:1771-2. 2003
Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 yearsEmma L Edghill
Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter EX2 5AX, UK
Diabetes 53:2998-3001. 2004..Although activating KCNJ11 mutations are rare in patients diagnosed with type 1 diabetes, the identification of a KCNJ11 mutation may have important treatment implications...
Do dogs develop autoimmune diabetes?Edwin A M Gale
Diabetologia 48:1945-7. 2005
The myth of the metabolic syndromeEdwin A M Gale
Diabetologia 48:1679-83. 2005
Association of intercellular adhesion molecule-1 gene with type 1 diabetesSergey Nejentsev
Juvenile Diabetes Research Foundation Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke s Hospital, CB2 2XY, Cambridge, UK
Lancet 362:1723-4. 2003..91, p=0.03; 446 families, 0.60, p=0.006). Our data indicate an aetiological role for ICAM-1 in type 1 diabetes, which needs to be confirmed in future genetic and functional experiments...
